Navigation Links
JCI early table of contents for Feb. 8, 2013
Date:2/8/2013

Rooting out recurrent breast cancer

Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy. In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment. Importantly, loss of TGF-β prevented tumor recurrence in mice. These studies identify a mechanism by which cancer cells elude standard chemotherapy and provide a rationale for testing the therapeutic potential of agents that block TGF-β.

TITLE:
TGFβ inhibition enhances chemotherapy action against triple negative breast cancer

AUTHOR CONTACT:
Carlos Arteaga
Vanderbilt University, Nashville, TN, USA
Phone: 615-936-3524; Fax: 615-936-1790; E-mail: carlos.arteaga@vanderbilt.edu

View this article at: http://www.jci.org/articles/view/65416?key=201b874c7a54cc627c43


Targeting T cells in rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disorder in which immune cells attack the joints, causing inflammation, swelling, and erosion. Specific sets of immune cells, known as T cells, are responsible for inducing disease. In this issue of the Journal of Clinical Investigation, researchers led by Harvey Cantor at Harvard University analyzed the contributions of different subsets of T cells to an RA-like condition in mice. Cantor and colleagues identified a subset of regulatory T cells (CD8+ Tregs) that can remove pathogenic T cell subsets and inhibit disease progression. Additionally, they identified small proteins that induced more CD8+ Tregs. These findings suggest that enhancing specific T cell subsets may be useful in combating RA and other autoimmune diseases.

TITLE:

Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T-cells

AUTHOR CONTACT:
Harvey Cantor
Dana Farber Cancer Institute, Boston, MA, USA
Phone: 617-632-3348; Fax: 617-632-4630; E-mail: harvey_cantor@dfci.harvard.edu

View this article at: http://www.jci.org/articles/view/66938?key=921590f51ca9f29cbc53


New insight into RASopathy-associated lymphatic defects

The RAS pathway is a cellular signaling pathway that regulates growth and development in humans. RASopathies are a group of diseases characterized by defects in RAS signaling. Many patients with RASopathies present with defects in the lymphatic system, which removes excess fluid from tissues, absorbs fats from the digestive system, and transports immune cells. To determine how alterations in the RAS pathway affect development of the lymphatic system, researchers at Yale University generated transgenic mice that expressed mutations associated with a RASopathy known as Noonan syndrome. In this issue of the Journal of Clinical Investigation, Michael Simon and colleagues report that excess RAS pathway activation triggers increased activity of a protein known as ERK. Mice with RASopathy-associated mutations exhibited lymphatic defects similar to those seen in humans, but the defects could be reversed by treatment with an ERK inhibitor. These findings demonstrate that excessive ERK activation underlies lymphatic defects in RASopathies and suggest that ERK inhibition could be a useful therapeutic strategy.

TITLE:
Endothelial ERK signaling controls lymphatic fate specification

AUTHOR CONTACT:
Michael Simons
Yale University School of Medicine, New Haven, CT, USA
Phone: 203-785-7000; Fax: 203-785-7144; E-mail: michael.simons@yale.edu

View this article at: http://www.jci.org/articles/view/63034?key=d664ce492ed2f61c7592

ALSO IN THIS ISSUE

TITLE:
Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism

AUTHOR CONTACT:
Michael Kormann
University of Tbingen, Tbingen, DEU
Phone: 49-707-129-84305; Fax: 49-70-712-94717; E-mail: kormann.michael@gmail.com

View this article at: http://www.jci.org/articles/view/65351?key=1acddb3759378c79fb19

TITLE:
CXCL5 limits macrophage foam cell formation in atherosclerosis

AUTHOR CONTACT:
Johan Duchene
Max Delbrck Center for Molecular Medicine, Berlin, DEU
Phone: +49 (0)30 9406-3592; E-mail: johan.duchene@mdc-berlin.de

View this article at: http://www.jci.org/articles/view/66580?key=23f5fa3db75c3616de65

TITLE:
SHP-1 phosphatase activity counteracts increased T cell receptor affinity

AUTHOR CONTACT:
Nathalie Rufer
University of Lausanne, Lausanne, UNK, CHE
Phone: +41 21 314 01 99; Fax: +41 21 314 74 77; E-mail: nathalie.rufer@unil.ch

View this article at: http://www.jci.org/articles/view/65325?key=462a82b5364e445f6d07

TITLE:
PAR-1 contributes to the innate immune response during viral infection

AUTHOR CONTACT:
Nigel Mackman
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Phone: 919 843 3961; Fax: 919 843 4896; E-mail: nmackman@med.unc.edu

View this article at: http://www.jci.org/articles/view/66125?key=6861131db424291005b5

TITLE:
Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling

AUTHOR CONTACT:
Clay F. Semenkovich
Washington University, St. Louis, MO, USA
Phone: 314-362-4454; E-mail: csemenko@dom.wustl.edu

View this article at: http://www.jci.org/articles/view/65726?key=115fd524a9c30f654cbe


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
2. Exposure to Smog in Early Pregnancy Linked to Complications
3. Mayo Clinic-led study identifies biomarkers for early risk assessment of acute kidney injury
4. Mammogram every 2 years has same benefit as yearly mammogram for older women, UCSF study finds
5. Early breast cancer diagnosis, survival rates low in rural India
6. JCI early table of contents for Feb. 1, 2013
7. Bioelectric signals can be used to detect early cancer
8. Blacks Less Likely to Receive Kidney Transplant Early On, Study Finds
9. Belly Fat May Raise Odds of Early Death for Thin Heart Patients
10. Sugar Addict Claims Americans Consuming 150 lbs of Sugar Yearly
11. New OHSU research helps explain early-onset puberty in females
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... Beleza Medspa has initiated a new program to assist active duty ... that Coolsculpting is being used for for more than just cosmetic purposes. ... prescribed body-fat standard, measured by the circumference-based tape method. The tape-test is used ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/27/2016)... ... ... With a team of certified experts, Validation Center is ... GMP accreditation, Validation Center is also a registered authority of the international system ... Validation Center is ISO17025 accredited and only offers its clients the latest technology, ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and 3M ... to court documents and SEC filings. A jury has returned a verdict ... Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... -- According to Kalorama Information, the world market for ... these are challenging times in the market, there ... companies that remain optimistic and seek innovation.  Toward ... medical device companies spend a higher percentage of ... do companies in other industries.  Also, in addition ...
(Date:5/25/2016)... PARIS , May 25, 2016 ... system disorders, announces that an oral presentation entitled "High doses ... the MS-SPI trial" will be given by Professor Ayman ... the 2nd Congress of the European Academy of Neurology (EAN) ... "MS and related disorders 3" will take place on Sunday, ...
Breaking Medicine Technology: